GBCS · Selectis Health, Inc.
$5.42
+0.12 (+2.26%)
At close · Aug 27
Going-concern doubt
— cleared Aug 24, 2026
The latest filing states the doubt was alleviated.
“As a result of the Company’s historical losses and projected cash needs, substantial doubt exists about the Company’s ability to continue as a going concern. The focus on opportunities within the Company’s current portfolio and future properties to acquire and operate, the settlement, refinance, and continued service of debt obligations, the potential funds generated from stock sales and other initiatives contributing to additional working capital should alleviate any substantial doubt about the Company’s ability to continue as a going concern.”View the 10-Q filed Aug 24, 2026
Market Cap
$16.62M
Shares
3.07M
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 4 and 5. Form 3 supplies initial ownership rather than a trade; Form 4 must be filed within two business days of the trade.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-01-01 | Desmond Adam |
Director, CEO |
Award↑
|
Common Stock Warrant
|
12,500 |
| 2025-12-31 | Desmond Adam |
Director, CEO |
Buy↑
|
Common Stock
|
1,300 |
| 2025-12-19 | Desmond Adam |
Director, CEO |
Buy↑
|
Common Stock
|
1,345 |
| 2025-12-18 | Baller Lance |
Director, 10% Owner |
Buy↑
|
Common Stock
(I)
|
6,192 |
| 2025-10-17 | Desmond Adam |
Director, CEO |
Buy↑
|
Common Stock
|
2,800 |
| 2025-10-09 | Desmond Adam |
Director, CEO |
Buy↑
|
Common Stock
|
240 |
| 2025-10-06 | Desmond Adam |
Director, CEO |
Buy↑
|
Common Stock
|
700 |
| 2025-08-01 | Desmond Adam |
Director, CEO |
Buy↑
|
Common Stock
|
619 |
| 2025-07-15 | Desmond Adam |
Director, CEO |
Buy↑
|
Common Stock
|
161 |
| 2025-06-12 | Desmond Adam |
Director, CEO |
Buy↑
|
Common Stock
|
360 |
| 2025-06-11 | Desmond Adam |
Director, CEO |
Buy↑
|
Common Stock
|
500 |
| 2025-06-11 | Desmond Adam |
Director, CEO |
Buy↑
|
Common Stock
|
70 |
| 2025-06-09 | Desmond Adam |
Director, CEO |
Buy↑
|
Common Stock
|
730 |
| 2025-06-03 | Desmond Adam |
Director, CEO |
Buy↑
|
Common Stock
|
47 |
| 2025-05-28 | Desmond Adam |
Director, CEO |
Buy↑
|
Common Stock
|
2 |
| 2025-05-15 | Desmond Adam |
Director, CEO |
Buy↑
|
Common Stock
|
10 |
| 2025-05-01 | Desmond Adam |
Director, CEO |
Buy↑
|
Common Stock
|
425 |
| 2025-05-01 | Desmond Adam |
Director, CEO |
Buy↑
|
Common Stock
|
815 |
| 2025-03-24 | Desmond Adam |
Director, CEO |
Buy↑
|
Common Stock
|
100 |
| 2025-03-20 | Desmond Adam |
Director, CEO |
Buy↑
|
Common Stock
|
5 |
| 2025-03-14 | Desmond Adam |
Director, CEO |
Buy↑
|
Common Stock
|
6 |
| 2025-03-05 | Desmond Adam |
Director, CEO |
Buy↑
|
Common Stock
|
900 |
| 2025-02-24 | Desmond Adam |
Director, CEO |
Buy↑
|
Common Stock
|
1,000 |
| 2025-02-20 | Desmond Adam |
Director, CEO |
Buy↑
|
Common Stock
|
2,500 |
| 2022-10-06 | Baller Lance |
Director, 10% Owner |
Buy↑
|
Common Stock
|
400 |
| 2022-10-06 | Baller Lance |
Director, 10% Owner |
Buy↑
|
Common Stock
|
100 |
| 2022-03-30 | Barker Christopher R. |
Director, PRESIDENT AND COO |
Award↑
|
Common Stock Options
|
100,000 |
| 2022-03-30 | Baller Lance |
Director, 10% Owner |
Award↑
|
Common Stock Options
|
100,000 |
| 2021-12-31 | Baller Lance |
Director, 10% Owner |
Other↑
|
Common Stock
(I)
|
20,000 |
| 2021-08-20 | Baller Lance |
Director, 10% Owner |
Award↑
|
Common Stock
(I)
|
100,000 |
| 2021-08-20 | Baller Lance |
Director, 10% Owner |
Award↑
|
Common Stock
(I)
|
66,667 |
| 2021-07-09 | Barker Christopher R. |
Director, PRESIDENT AND COO |
Buy↑
|
Common Stock
|
50,000 |
| 2021-07-09 | NEUMAN CLIFFORD L ESQ |
Director |
Buy↑
|
Common Stock
|
100,000 |
| 2021-07-09 | Thall Brandon |
CFO |
Buy↑
|
Common Stock
|
20,000 |
Legend
Buy — open-market purchase
Sell — open-market sale
↑ Shares acquired
↓ Shares disposed (gift, conversion, tax…)
Showing 1–34 of 34 transactions